EMPA-KIDNEY Trademark

Trademark Overview


On Saturday, May 7, 2022, a trademark application was filed for EMPA-KIDNEY with the United States Patent and Trademark Office. The USPTO has given the EMPA-KIDNEY trademark a serial number of 79344375. The federal status of this trademark filing is REGISTERED as of Tuesday, November 14, 2023. This trademark is owned by Boehringer Ingelheim International GmbH. The EMPA-KIDNEY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of diabetes, chronic kidney diseases and cardiovascular diseases; providing medical and scientific research information in the field of diabetes, chronic kidney diseases and cardiovascular diseases
empa-kidney

General Information


Serial Number79344375
Word MarkEMPA-KIDNEY
Filing DateSaturday, May 7, 2022
Status700 - REGISTERED
Status DateTuesday, November 14, 2023
Registration Number7215367
Registration DateTuesday, November 14, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 29, 2023

Trademark Statements


Goods and ServicesMedical and scientific research in the field of diabetes, chronic kidney diseases and cardiovascular diseases; providing medical and scientific research information in the field of diabetes, chronic kidney diseases and cardiovascular diseases

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 8, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Monday, March 4, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, February 15, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 15, 2024FINAL DISPOSITION PROCESSED
Wednesday, February 14, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 14, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 29, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 29, 2023PUBLISHED FOR OPPOSITION
Monday, August 28, 2023NOTIFICATION PROCESSED BY IB
Wednesday, August 9, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 9, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 9, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 13, 2023REFUSAL PROCESSED BY IB
Friday, March 17, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 17, 2023REFUSAL PROCESSED BY MPU
Wednesday, January 25, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 24, 2023NON-FINAL ACTION WRITTEN
Tuesday, January 24, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, January 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 20, 2023ASSIGNED TO EXAMINER
Friday, December 30, 2022ASSIGNED TO EXAMINER
Tuesday, July 12, 2022APPLICATION FILING RECEIPT MAILED
Friday, July 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 7, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB